2026 Q1 Earnings Review NDR Hosted by Sangsangin Securities
-
Holding a Non-Deal Roadshow (NDR) for domestic institutional investors: April 29-30, 2026 in Yeouido, Seoul
-
Purpose: Review 2026 Q1 performance and update global industry trends, hosted by Sangsangin Securities
-
IR materials to be posted on KRX and company website on April 29, 2026
KOSDAQ Filing Information
-
Filing: Holding of Investor Relations Conference (IR)
-
Company: ST PHARM (237690)
-
Submission: ST PHARM CO., LTD.
-
Receipt: 04-27-2026
-
Under KRX KOSDAQ Market Division